Fecal calprotectin - Revision history

Michael at 17:13, 16 February 2019

2019-02-16T17:13:58Z

← Older revision		Revision as of 17:13, 16 February 2019
Line 1:		Line 1:
	'''Fecal calprotectin''' is a 36kDa protein and an inflammatory marker.<ref name=pmid30342711>{{Cite journal \| last1 = Ayling \| first1 = RM. \| last2 = Kok \| first2 = K. \| title = Fecal Calprotectin. \| journal = Adv Clin Chem \| volume = 87 \| issue = \| pages = 161-190 \| month = \| year = 2018 \| doi = 10.1016/bs.acc.2018.07.005 \| PMID = 30342711 }}</ref>		'''Fecal calprotectin''' is a 36kDa protein and an inflammatory marker.<ref name=pmid30342711>{{Cite journal \| last1 = Ayling \| first1 = RM. \| last2 = Kok \| first2 = K. \| title = Fecal Calprotectin. \| journal = Adv Clin Chem \| volume = 87 \| issue = \| pages = 161-190 \| month = \| year = 2018 \| doi = 10.1016/bs.acc.2018.07.005 \| PMID = 30342711 }}</ref>

	It is useful to ~~differentiated~~ [[inflammatory bowel disease]] (IBD) from [[irritable bowel syndrome]],<ref name=pmid30407259>{{Cite journal \| last1 = Nemakayala \| first1 = DR. \| last2 = Cash \| first2 = BD. \| title = Excluding irritable bowel syndrome in the inflammatory bowel disease patient: how far to go? \| journal = Curr Opin Gastroenterol \| volume = 35 \| issue = 1 \| pages = 58-62 \| month = Jan \| year = 2019 \| doi = 10.1097/MOG.0000000000000493 \| PMID = 30407259 }}</ref> and may be used to assess IBD activity.		It is useful to differentiate [[inflammatory bowel disease]] (IBD) from [[irritable bowel syndrome]],<ref name=pmid30407259>{{Cite journal \| last1 = Nemakayala \| first1 = DR. \| last2 = Cash \| first2 = BD. \| title = Excluding irritable bowel syndrome in the inflammatory bowel disease patient: how far to go? \| journal = Curr Opin Gastroenterol \| volume = 35 \| issue = 1 \| pages = 58-62 \| month = Jan \| year = 2019 \| doi = 10.1097/MOG.0000000000000493 \| PMID = 30407259 }}</ref> and may be used to assess IBD activity.

	==See also==		==See also==

Michael at 17:12, 16 February 2019

2019-02-16T17:12:39Z

← Older revision		Revision as of 17:12, 16 February 2019
Line 1:		Line 1:
	'''Fecal calprotectin''' is a 36kDa protein and an inflammatory marker.<ref name=pmid30342711>{{Cite journal \| last1 = Ayling \| first1 = RM. \| last2 = Kok \| first2 = K. \| title = Fecal Calprotectin. \| journal = Adv Clin Chem \| volume = 87 \| issue = \| pages = 161-190 \| month = \| year = 2018 \| doi = 10.1016/bs.acc.2018.07.005 \| PMID = 30342711 }}</ref>		'''Fecal calprotectin''' is a 36kDa protein and an inflammatory marker.<ref name=pmid30342711>{{Cite journal \| last1 = Ayling \| first1 = RM. \| last2 = Kok \| first2 = K. \| title = Fecal Calprotectin. \| journal = Adv Clin Chem \| volume = 87 \| issue = \| pages = 161-190 \| month = \| year = 2018 \| doi = 10.1016/bs.acc.2018.07.005 \| PMID = 30342711 }}</ref>

	It is useful to differentiated IBD from irritable bowel syndrome,<ref>{{Cite journal \| last1 = Nemakayala \| first1 = DR. \| last2 = Cash \| first2 = BD. \| title = Excluding irritable bowel syndrome in the inflammatory bowel disease patient: how far to go? \| journal = Curr Opin Gastroenterol \| volume = 35 \| issue = 1 \| pages = 58-62 \| month = Jan \| year = 2019 \| doi = 10.1097/MOG.0000000000000493 \| PMID = 30407259 }}		It is useful to differentiated [[inflammatory bowel disease]] (IBD) from [[irritable bowel syndrome]],<ref name=pmid30407259>{{Cite journal \| last1 = Nemakayala \| first1 = DR. \| last2 = Cash \| first2 = BD. \| title = Excluding irritable bowel syndrome in the inflammatory bowel disease patient: how far to go? \| journal = Curr Opin Gastroenterol \| volume = 35 \| issue = 1 \| pages = 58-62 \| month = Jan \| year = 2019 \| doi = 10.1097/MOG.0000000000000493 \| PMID = 30407259 }}</ref> and may be used to assess IBD activity.
	</ref> and may be used to assess IBD activity.

	==See also==		==See also==

Michael at 17:11, 16 February 2019

2019-02-16T17:11:56Z

← Older revision		Revision as of 17:11, 16 February 2019
Line 1:		Line 1:
	'''Fecal calprotectin''' is a 36kDa protein and an inflammatory marker.<ref>{{Cite journal \| last1 = Ayling \| first1 = RM. \| last2 = Kok \| first2 = K. \| title = Fecal Calprotectin. \| journal = Adv Clin Chem \| volume = 87 \| issue = \| pages = 161-190 \| month = \| year = 2018 \| doi = 10.1016/bs.acc.2018.07.005 \| PMID = 30342711 }}</ref>		'''Fecal calprotectin''' is a 36kDa protein and an inflammatory marker.<ref name=pmid30342711>{{Cite journal \| last1 = Ayling \| first1 = RM. \| last2 = Kok \| first2 = K. \| title = Fecal Calprotectin. \| journal = Adv Clin Chem \| volume = 87 \| issue = \| pages = 161-190 \| month = \| year = 2018 \| doi = 10.1016/bs.acc.2018.07.005 \| PMID = 30342711 }}</ref>

			It is useful to differentiated IBD from irritable bowel syndrome,<ref>{{Cite journal \| last1 = Nemakayala \| first1 = DR. \| last2 = Cash \| first2 = BD. \| title = Excluding irritable bowel syndrome in the inflammatory bowel disease patient: how far to go? \| journal = Curr Opin Gastroenterol \| volume = 35 \| issue = 1 \| pages = 58-62 \| month = Jan \| year = 2019 \| doi = 10.1097/MOG.0000000000000493 \| PMID = 30407259 }}
			</ref> and may be used to assess IBD activity.

	==See also==		==See also==

Michael: create

2019-02-16T17:09:10Z

create

New page

'''Fecal calprotectin''' is a 36kDa protein and an inflammatory marker.<ref>{{Cite journal | last1 = Ayling | first1 = RM. | last2 = Kok | first2 = K. | title = Fecal Calprotectin. | journal = Adv Clin Chem | volume = 87 | issue = | pages = 161-190 | month = | year = 2018 | doi = 10.1016/bs.acc.2018.07.005 | PMID = 30342711 }}</ref>

==See also==
*[[Inflammatory bowel disease]].

==References==
{{Reflist|1}}

[[Category:Clinical]]